Literature DB >> 2508018

Panendoscopy: a valuable procedure?

G J Hordijk1, T Bruggink, L A Ravasz.   

Abstract

The significance of panendoscopy, performed as part of the routine diagnostic procedure, must be questioned when the incidence of synchronous primary tumors found by this procedure is only 1% to 2%, as in patients with head and neck cancer in the Dutch population. In order to detect a group of patients with a higher probability of secondary tumors, patients were selected for panendoscopy on the following criteria: localization and histology of the index tumors, as well as on smoking and drinking habits. In spite of this selection, the yield of panendoscopy was still below 2%. Until other criteria for the selection of a subset of patients with a high incidence of synchronous tumours are found, the indication for panendoscopy as part of a routine diagnostic procedure has to be constantly questioned, and panendoscopy should therefore be performed only when this procedure is part of a prospective study.

Entities:  

Mesh:

Year:  1989        PMID: 2508018     DOI: 10.1177/019459988910100403

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  6 in total

1.  Role of panendoscopy in identifying and managing risk of head and neck squamous cell carcinoma in routine follow-up: a retrospective clinical evaluation.

Authors:  Adrian Münscher; Susanne Sehner; Jegane Taleh; Silke Tribius; Nicolaus Möckelmann; Arne Böttcher; Amit Gulati; Carsten Dalchow; Till Clauditz; Rainald Knecht
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-07       Impact factor: 2.503

2.  Preoperative evaluation of patients with primary head and neck cancer using dual-head 18fluorodeoxyglucose positron emission tomography.

Authors:  M P Stokkel; F W ten Broek; G J Hordijk; R Koole; P P van Rijk
Journal:  Ann Surg       Date:  2000-02       Impact factor: 12.969

3.  Panendoscopy as a screening procedure for simultaneous primary tumors in head and neck cancer.

Authors:  I J Dhooge; M De Vos; F W Albers; P B Van Cauwenberge
Journal:  Eur Arch Otorhinolaryngol       Date:  1996       Impact factor: 2.503

Review 4.  Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.

Authors:  Hubert Vermeersch; David Loose; Hamphrey Ham; Andreas Otte; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-22       Impact factor: 9.236

5.  Diagnosis of second primary tumor and long-term survival after single initial triple endoscopy in patients with head and neck cancer.

Authors:  Antonio Vitor Martins Priante; Jefferson Luiz Gross; Claudia Zitron Sztokfisz; Inês Nobuko Nishimoto; Luiz Paulo Kowalski
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-10-18       Impact factor: 2.503

6.  The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year period.

Authors:  Kuan-Der Lee; Chang-Hsien Lu; Ping-Tsung Chen; Chunghuang Hubert Chan; Jen-Tsun Lin; Cih-En Huang; Chih-Cheng Chen; Min-Chi Chen
Journal:  BMC Cancer       Date:  2009-10-20       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.